Skip to main content
SpringerLink
Log in

Adherence in Atopic Dermatitis

  • Chapter
  • First Online:
Adherence in Dermatology

  • 652 Accesses

Abstract

As defined by the UK Working Party’s diagnostic criteria [1], atopic dermatitis (AD), also known as atopic eczema, is a relapsing, chronic, inflammatory, cutaneous disorder that occurs mainly in childhood and sometimes persists into adulthood [2]. AD currently affects 10–30 % of children worldwide [3, 4]. It is a public health concern because of its prevalence, cost, and impact on quality of life. Atopic eczema in children can indeed have a profound effect on quality of life, causing major sleep disruption for the child and family and interfering with normal development, education, and play. Thus, the broad impact of AD warrants optimization of relevant support services.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Williams HC, Burney PG, Pembroke AC, Hay RJ (1994) The U.K. working party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 131(3):406–416

    Article  CAS  PubMed  Google Scholar 

  2. Silverberg JI, Hanifin JM (2013) Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 132(5):1132–1138

    Article  PubMed  Google Scholar 

  3. Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483–1494, 3 avr

    Article  CAS  PubMed  Google Scholar 

  4. Spergel JM (2010) Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 30(3):269–280

    Article  PubMed  Google Scholar 

  5. Tan X, Feldman SR, Chang J, Balkrishnan R (2012) Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv 9(10):1263–1271

    Article  CAS  PubMed  Google Scholar 

  6. Koehler AM, Maibach HI (2001) Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol 2(1):7–12

    Article  CAS  PubMed  Google Scholar 

  7. Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D et al (2007) Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 56(2):211–216

    Article  PubMed  Google Scholar 

  8. Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR (2010) Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol JDD 9(4):324–329

    PubMed  Google Scholar 

  9. Furue M, Onozuka D, Takeuchi S, Murota H, Sugaya M, Masuda K et al (2015) Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol 172(1):272–275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hix E, Gustafson CJ, O’Neill JL, Huang K, Sandoval LF, Harrison J et al (2013) Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J 19(10):20029

    PubMed  Google Scholar 

  11. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E et al (2010) Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis 86(4):208–213

    PubMed  Google Scholar 

  12. Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J (2013) Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr 104(5):409–417

    Article  CAS  PubMed  Google Scholar 

  13. Ortiz de Frutos FJ, Torrelo A, de Lucas R, González MA, Alomar A, Vera Á et al (2014) Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP study. Actas Dermosifiliogr 105(5):487–496

    Article  CAS  PubMed  Google Scholar 

  14. Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22(4):313–356

    Article  PubMed  Google Scholar 

  15. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

    Article  CAS  PubMed  Google Scholar 

  16. Gupta G, Mallefet P, Kress DW, Sergeant A (2009) Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 161(2):221–227

    Article  CAS  PubMed  Google Scholar 

  17. Beattie PE, Lewis-Jones MS (2003) Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 28(5):549–553

    Article  CAS  PubMed  Google Scholar 

  18. Fenerty SD, O’Neill JL, Gustafson CJ, Feldman SR (2013) Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol 149(2):229–231

    Article  PubMed  Google Scholar 

  19. Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R et al (2001) Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 117(4):852–857

    Article  CAS  PubMed  Google Scholar 

  20. Santer M, Burgess H, Yardley L, Ersser SJ, Lewis-Jones S, Muller I et al (2013) Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs 69(11):2493–2501

    PubMed  Google Scholar 

  21. Tuft L (1979) «Steroid-phobia» in asthma management. Ann Allergy 42(3):152–159

    CAS  PubMed  Google Scholar 

  22. David TJ (1987) Steroid scare. Arch Dis Child 62(9):876–878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Patterson R, Walker CL, Greenberger PA, Sheridan EP (1989) Prednisonephobia. Allergy Proc Off J Reg State Allergy Soc 10(6):423–428

    Article  CAS  Google Scholar 

  24. Fischer G (1996) Compliance problems in paediatric atopic eczema. Australas J Dermatol 37(Suppl 1):S10–S13

    Article  PubMed  Google Scholar 

  25. Charman CR, Morris AD, Williams HC (2000) Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 142(5):931–936

    Article  CAS  PubMed  Google Scholar 

  26. Hon K-LE, Kam W-YC, Leung T-F, Lam M-CA, Wong K-Y, Lee K-CK et al (2006) Steroid fears in children with eczema. Acta Paediatr Oslo Nor 1992 95(11):1451–1455

    Google Scholar 

  27. Kojima R, Fujiwara, Matsuda, Narita, Matsubara. Factors associated with steroid pho… [Pediatr Dermatol. 2013 Jan-Feb] – PubMed – NCBI [Internet]. [cité 20 janv 2014]. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/22747965

  28. Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C et al (2011) Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol 165(4):808–814

    Article  CAS  PubMed  Google Scholar 

  29. Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB, Balkrishnan R et al (2008) Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J 14(9):13

    PubMed  Google Scholar 

  30. Thomas KS, Armstrong S, Avery A, Po ALW, O’Neill C, Young S et al (2002) Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 324(7340):768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ (1999) The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 140(6):1114–1121

    Google Scholar 

  32. Davis SA, Lin H-C, Yu C-H, Balkrishnan R, Feldman SR (2014) Underuse of early follow-up visits: a missed opportunity to improve patients’ adherence. J Drugs Dermatol JDD 13(7):833–836

    PubMed  Google Scholar 

  33. Shah A, Yentzer BA, Feldman SR (2013) Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis 91(2):105–107

    PubMed  Google Scholar 

  34. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R (2004) Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 51(2):212–216

    Article  PubMed  Google Scholar 

  35. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57(1):81–83

    Article  PubMed  Google Scholar 

  36. Trookman NS, Rizer RL, Ho ET, Ford RO, Gotz V (2011) The importance of vehicle properties to patients with atopic dermatitis. Cutis 88(1 Suppl):13–17

    PubMed  Google Scholar 

  37. Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94(1):46–53

    PubMed  Google Scholar 

  38. Barbarot S, Bernier C, Deleuran M, De Raeve L, Eichenfield L, El Hachem M et al (2013) Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol 30(2):199–206

    Article  PubMed  Google Scholar 

  39. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR (2008) Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 59(4):677–683

    Article  PubMed  Google Scholar 

  40. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149(3):582–9

    Google Scholar 

  41. Bewley A, Dermatology Working Group (2008) Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 158(5):917–920

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Department, Ecole de l’atopie, CHU de Nantes, CHU Hôtel Dieu, Nantes, 44035, France

    Hélène Aubert MD & Sébastien Barbarot MD, PhD

Authors
  1. Hélène Aubert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sébastien Barbarot MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sébastien Barbarot MD, PhD .

Editor information

Editors and Affiliations

  1. Eshelman Sch of Pharma, CB#7355, University of North Carolina, Chapel Hill, North Carolina, USA

    Scott A. Davis

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Aubert, H., Barbarot, S. (2016). Adherence in Atopic Dermatitis. In: Davis, S. (eds) Adherence in Dermatology. Adis, Cham. https://doi.org/10.1007/978-3-319-30994-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30994-1_11

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-30992-7

  • Online ISBN: 978-3-319-30994-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation